Content about insomnia treatment

October 4, 2011
Insomnia treatment under consideration for Rx-to-OTC switch

Insomnnia may be the next big treatment regimen to make a switch from prescription-only to over the counter.

January 31, 2011
Transcept announces PDUFA action date for Intermezzo

Transcept announced Monday that the Food and Drug Administration has classified the drug maker's insomnia treatment as a complete class-2 response, and assigned the drug a Prescription Drug User Fee Act action date for this summer.

August 29, 2010
Somaxon, P&G to co-promote Silenor

A drug maker and a consumer packaged goods company will co-promote a newly approved insomnia...

© 2013 Drug Store News. All Rights Reserved.